Predatory bacteria – that eat
others of their kind – could be a new weapon in the fight against
drug-resistant bacteria or ‘superbug’, a new study suggests. A naturally
occurring predatory bacterium is able to work with the immune system to clear
multi-drug resistant Shigella infections in zebra-fish, researchers from
Imperial College of London and Nottingham University in the UK said. It is the
first time the predatory bacterium Bdellovibrio bacteriovorous has been
successfully used as an injected anti-bacterial therapy and represents an
important step in the fight against drug-resistant infections, or ‘superbugs’. Shigella
infection is responsible for over 160 million illnesses and over one million
deaths every year – and is a common cause of travelers’ diarrhea. Cases of
drug-resistant Shigella are also on the rise as, although the diarrhea usually
clears up without treatment, antibiotics are often used even in mild cases to
stop the diarrhea faster. To investigate Bdellovibrio’s ability to control drug
resistant Gram-negative infections, researchers injected zebra-fish larvae with
a lethal dose of Shigella flexneri strain M90T, resistant to antibiotics.
Bdellovibrio was injected into the larvae’s infection site and a decrease in
the number of Shigella was seen. In the absence of Bdellovibrio, zebra-fish
Shigella numbers rose.
No comments:
Post a Comment